Clinical Trials Logo

Contraceptive Usage clinical trials

View clinical trials related to Contraceptive Usage.

Filter by:

NCT ID: NCT04780243 Active, not recruiting - Contraceptive Usage Clinical Trials

Expanded Program for Immunization, a Missed Opportunity for Postpartum Family Planning Utilization

Start date: February 1, 2020
Phase: N/A
Study type: Interventional

This study is aimed to enhance postpartum family planning by integrating family planning information with infant immunization services, which is the most widely utilized health services globally.

NCT ID: NCT04725643 Active, not recruiting - Contraception Clinical Trials

Keep Contraceptive Arm Long Acting-iMplant (CALM) and Carry On

CALM
Start date: February 17, 2022
Phase:
Study type: Observational

The investigators will conduct an observational study comparing the number of bleeding days before and after contraceptive implant (Nexplanon) replacement.

NCT ID: NCT04558229 Recruiting - Contraception Clinical Trials

RCT Evaluating Standardized Counseling on Early Discontinuation for Irregular Bleeding in Nexplanon Users

Start date: November 24, 2020
Phase: Phase 4
Study type: Interventional

Clinician counseling for implant users should involve an explanation of the likelihood of irregular bleeding and the possibility of continued or frequent bleeding throughout three years of use. If that counseling does not provide specifics of the actual distribution of bleeding patterns described in published literature, there remains the real possibility of biased or directed counseling, leading to an inaccurate and exaggerated expectation of potential bleeding changes. This study aims to evaluate if a standardized script accompanied by a visual aid regarding expected bleeding profiles, with intention to remove any possibility of negative or positive framing, could change users' expectations and satisfaction with their method, leading to lower discontinuation rates.

NCT ID: NCT04423068 Completed - Pregnancy Clinical Trials

Inpatient Adolescent Contraception

Start date: December 10, 2020
Phase: Early Phase 1
Study type: Interventional

The overall goal of this study is to refine and pilot test the investigators novel intervention to offer contraception counseling and initiation for hospitalized female adolescents, focusing on long acting reversible contraception (LARC).

NCT ID: NCT04365426 Completed - Contraceptive Usage Clinical Trials

Effects of Oral Contraceptives on DNIC in Non-painful Healthy Women

Start date: April 24, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is tu assess the influence of oral contraceptives (OC) on diffuse noxious inhibitory control (DNIC) in healthy women, tested during high, low endogenous estrogens sessions and ovulatory period.

NCT ID: NCT04262882 Completed - Contraceptive Usage Clinical Trials

Multilevel Family Planning Intervention

Start date: May 14, 2021
Phase: N/A
Study type: Interventional

This study seeks to develop and evaluate a multi-level intervention to satisfy couples' unmet need for family planning in rural Uganda. The study will evaluate the acceptability, feasibility, and preliminary efficacy of the intervention at increasing contraceptive uptake and continuation and improving intermediate outcomes of knowledge, attitudes, perceived community norms, partner communication and equity among couples in rural Uganda.

NCT ID: NCT04227145 Completed - Contraception Clinical Trials

SexHealth Mobile: Integrating a Mobile Clinic and a Point-of-care Contraception Counseling and Access

Start date: March 2, 2020
Phase: N/A
Study type: Interventional

Pilot study aims to evaluate the effectiveness of "SexHealth Mobile" and improve access to highly effective contraception among women with substance use disorder (SUD) with "SexHealth Mobile" intervention. This intervention will consist of two existing services that will help reach women with or recovering from SUD and provide access to contraception, as well as counseling.

NCT ID: NCT04222504 Recruiting - Contraceptive Usage Clinical Trials

Community-based Venues for Delivery of Healthcare Services: Proof of Concept Pilot

Start date: February 8, 2021
Phase: N/A
Study type: Interventional

The investigators propose to offer a package of evidence-based health services to women in three hair salons in the Umlazi township of Durban. Based on community feedback in previous survey and qualitative work, the package has been designed to include daily PrEP, family planning/contraceptives, and STI screening. Interested salon clients at intervention salons will elect which services to use. An additional three salons will serve as controls, offering no health services to clients. Surveys will be conducted in both salon groups. Attendance at follow-up visits for monitoring and medication refill will be encouraged using text message reminders, WhatsApp support groups, and lottery-based incentives for free salon services. Recruitment in intervention salons will conclude when 200 clients uptake PrEP. Two hundred participants will be recruited in control salons.

NCT ID: NCT04068870 Recruiting - Contraceptive Usage Clinical Trials

Testing a Modified Family Planning Intervention for Postpartum Women in Uganda

Start date: August 5, 2019
Phase: Phase 1
Study type: Interventional

The purpose of this study is to test whether offering incentives to encourage women to attend one-on-one family planning education sessions and offering free, onsite prescription contraceptive methods increases use and continuation of prescription contraception among postpartum women in Uganda. This intervention is modified from one that has been effective outside of Uganda.

NCT ID: NCT04043130 Completed - Contraceptive Usage Clinical Trials

The Evaluation of Pulse: A Mobile Health App and Teen Pregnancy Prevention Program

Start date: November 2016
Phase: N/A
Study type: Interventional

This study used a randomized controlled design to evaluate the efficacy of a new mobile app, Pulse, in reducing the incidence of unprotected sex among young women. Pulse is a web-based mobile health application that can be accessed through mobile smartphones and computers. Pulse was designed to increase highly effective birth control use and reproductive and sexual health care utilization, and ultimately decrease teen pregnancy. The sample was comprised of 2,317 women aged 18-20 who, at enrollment, were not pregnant or trying to become pregnant, had daily access to a smartphone, were currently living in the United States or a U.S. territory, and spoke English. Most of the sample (86%) identified as Black and/or Latinx. The evaluation team enrolled participants over a two and a half year enrollment period using social media, including Facebook and Instagram. Users accessed Pulse autonomously, on their own terms, and in their own time and place. The app consists of 6 sections and includes 3 hours of unique content. It does not require the user to follow a specific sequence of content viewed; however, all users received a monetary incentive after registering with the app. Young women randomized to the intervention condition were given access to Pulse indefinitely and received daily text messages related to sexual health for 6 weeks. Control participants were directed to a free general health/fitness web-based mobile application, also called Pulse, and received text messages related to general health for 6 weeks. The control and treatment apps look and feel similar aesthetically but contain different content. Participants in both the intervention and comparison groups received a baseline survey, a 6-week follow-up survey, and a 6-month follow-up survey (the 6-month follow-up survey was only administered to participants recruited between November 2018 and March 2019). Participants also received incentives for completing the baseline and post-intervention surveys. Both surveys were conducted online via an electronic survey platform. This study was conducted as a Rigorous Evaluation of New or Innovative Approaches to Prevent Teen Pregnancy funded by the U.S. Department of Health and Human Services' Office of Adolescent Health.